Fig. 5From: Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group studySputum biomarkers (ratio; 90% CI) 1 week after last dose, prior to allergen challengeBack to article page